Psychiatric Drugs Explained
portes grátis
Psychiatric Drugs Explained
Healy, David
Elsevier Health Sciences
05/2022
356
Mole
Inglês
9780702083907
15 a 20 dias
580
Descrição não disponível.
Section 1 Management of the psychoses
2 The antipsychotics
3 Antipsychotic side effects and their management
References
Section 2 Management of depression
4 The antidepressants
5 Side effects of antidepressants
References
Section 3 Management of bipolar disorders
6 Management of acute bipolar disorder
7 Mood-stabilisers
References
Section 4 Stimulants & Drugs for children
8 Stimulants & Drugs for children
References
Section 5 Management of anxiety
8 The anxiety disorders
10 Benzodiazepine anxiolytics
11 Anxiolysis and the serotonin system
12 Beta-blockers and anxiety
References
Section 6 Management of sleep disorders and insomnia
13 Sleep disorders and insomnia
14 Non-pharmacological management of insomnia
15 Hypnotics
16 Sedatives
References
Section 7 Management of cognitive impairment
17 Cognitive enhancement and the dementias
18 Cognitive enhancement and neuroprotection
References
Section 8 Management of sexual difficulties
19 The range of sexual difficulties
20 Effects of drugs on aspects of sexual functioning
Appendix 20.1 Male sexual functioning questionnaire
Appendix 20.2 Female sexual functioning questionnaire
References
Section 9 Management of dependence and withdrawal
21 Dependence & Withdrawal
22 Dependence & Craving
23 Dependence & Protracted Withdrawal
References
Section 10 Consent, abuse and liability
24 Consent
25 Pharmacological abuse
References
Section 11 The marketing of tranquillity
26 The ethical industry
27 Evidence-biased care
28 Marketing & Risk
29 From healthcare to pharmageddon
2 The antipsychotics
3 Antipsychotic side effects and their management
References
Section 2 Management of depression
4 The antidepressants
5 Side effects of antidepressants
References
Section 3 Management of bipolar disorders
6 Management of acute bipolar disorder
7 Mood-stabilisers
References
Section 4 Stimulants & Drugs for children
8 Stimulants & Drugs for children
References
Section 5 Management of anxiety
8 The anxiety disorders
10 Benzodiazepine anxiolytics
11 Anxiolysis and the serotonin system
12 Beta-blockers and anxiety
References
Section 6 Management of sleep disorders and insomnia
13 Sleep disorders and insomnia
14 Non-pharmacological management of insomnia
15 Hypnotics
16 Sedatives
References
Section 7 Management of cognitive impairment
17 Cognitive enhancement and the dementias
18 Cognitive enhancement and neuroprotection
References
Section 8 Management of sexual difficulties
19 The range of sexual difficulties
20 Effects of drugs on aspects of sexual functioning
Appendix 20.1 Male sexual functioning questionnaire
Appendix 20.2 Female sexual functioning questionnaire
References
Section 9 Management of dependence and withdrawal
21 Dependence & Withdrawal
22 Dependence & Craving
23 Dependence & Protracted Withdrawal
References
Section 10 Consent, abuse and liability
24 Consent
25 Pharmacological abuse
References
Section 11 The marketing of tranquillity
26 The ethical industry
27 Evidence-biased care
28 Marketing & Risk
29 From healthcare to pharmageddon
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Section 1 Management of the psychoses
2 The antipsychotics
3 Antipsychotic side effects and their management
References
Section 2 Management of depression
4 The antidepressants
5 Side effects of antidepressants
References
Section 3 Management of bipolar disorders
6 Management of acute bipolar disorder
7 Mood-stabilisers
References
Section 4 Stimulants & Drugs for children
8 Stimulants & Drugs for children
References
Section 5 Management of anxiety
8 The anxiety disorders
10 Benzodiazepine anxiolytics
11 Anxiolysis and the serotonin system
12 Beta-blockers and anxiety
References
Section 6 Management of sleep disorders and insomnia
13 Sleep disorders and insomnia
14 Non-pharmacological management of insomnia
15 Hypnotics
16 Sedatives
References
Section 7 Management of cognitive impairment
17 Cognitive enhancement and the dementias
18 Cognitive enhancement and neuroprotection
References
Section 8 Management of sexual difficulties
19 The range of sexual difficulties
20 Effects of drugs on aspects of sexual functioning
Appendix 20.1 Male sexual functioning questionnaire
Appendix 20.2 Female sexual functioning questionnaire
References
Section 9 Management of dependence and withdrawal
21 Dependence & Withdrawal
22 Dependence & Craving
23 Dependence & Protracted Withdrawal
References
Section 10 Consent, abuse and liability
24 Consent
25 Pharmacological abuse
References
Section 11 The marketing of tranquillity
26 The ethical industry
27 Evidence-biased care
28 Marketing & Risk
29 From healthcare to pharmageddon
2 The antipsychotics
3 Antipsychotic side effects and their management
References
Section 2 Management of depression
4 The antidepressants
5 Side effects of antidepressants
References
Section 3 Management of bipolar disorders
6 Management of acute bipolar disorder
7 Mood-stabilisers
References
Section 4 Stimulants & Drugs for children
8 Stimulants & Drugs for children
References
Section 5 Management of anxiety
8 The anxiety disorders
10 Benzodiazepine anxiolytics
11 Anxiolysis and the serotonin system
12 Beta-blockers and anxiety
References
Section 6 Management of sleep disorders and insomnia
13 Sleep disorders and insomnia
14 Non-pharmacological management of insomnia
15 Hypnotics
16 Sedatives
References
Section 7 Management of cognitive impairment
17 Cognitive enhancement and the dementias
18 Cognitive enhancement and neuroprotection
References
Section 8 Management of sexual difficulties
19 The range of sexual difficulties
20 Effects of drugs on aspects of sexual functioning
Appendix 20.1 Male sexual functioning questionnaire
Appendix 20.2 Female sexual functioning questionnaire
References
Section 9 Management of dependence and withdrawal
21 Dependence & Withdrawal
22 Dependence & Craving
23 Dependence & Protracted Withdrawal
References
Section 10 Consent, abuse and liability
24 Consent
25 Pharmacological abuse
References
Section 11 The marketing of tranquillity
26 The ethical industry
27 Evidence-biased care
28 Marketing & Risk
29 From healthcare to pharmageddon
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.